Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kallio

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Human Reproduction (Oxford, England)|January 20, 2012
Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovariesS Kallio, K Aittomäki, T Piltonen, et al.
European Journal of Neurology|August 14, 2017
Neglect and aphasia in the acute phase as predictors of functional outcome 7 years after ischemic strokeJ Gerafi, H Samuelsson, J I Viken, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A new triphenylethylene compound, Fc-1157a. II. Antitumor effectsL Kangas, A L Nieminen, G Blanco, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A new triphenylethylene compound, Fc-1157a. I. Hormonal effectsS Kallio, L Kangas, G Blanco, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Human Reproduction (Oxford, England)|January 20, 2012
Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovariesS Kallio, K Aittomäki, T Piltonen, et al.
European Journal of Neurology|August 14, 2017
Neglect and aphasia in the acute phase as predictors of functional outcome 7 years after ischemic strokeJ Gerafi, H Samuelsson, J I Viken, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A new triphenylethylene compound, Fc-1157a. II. Antitumor effectsL Kangas, A L Nieminen, G Blanco, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A new triphenylethylene compound, Fc-1157a. I. Hormonal effectsS Kallio, L Kangas, G Blanco, et al.
Pageof 2